Literature DB >> 23042934

Re: Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.

Massimo Rugge, Matteo Fassan, Francesco Cavallin, Francesco Cavallini, Giovanni Zaninotto.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23042934     DOI： 10.1093/jnci/djs426

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Barrett's oesophagus: Current controversies.

Authors:  Chidi Amadi; Piers Gatenby
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

2.  Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer.

Authors:  Elisa Boldrin; Sandro Malacrida; Enrica Rumiato; Giorgio Battaglia; Alberto Ruol; Alberto Amadori; Daniela Saggioro
Journal:  Front Oncol       Date:  2019-02-21       Impact factor: 6.244

3.  MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia.

Authors:  Matteo Fassan; Stefano Volinia; Jeff Palatini; Marco Pizzi; Cecilia Fernandez-Cymering; Mariangela Balistreri; Stefano Realdon; Giorgio Battaglia; Rhonda Souza; Robert D Odze; Giovanni Zaninotto; Carlo M Croce; Massimo Rugge Md Facg
Journal:  Clin Transl Gastroenterol       Date:  2013-05-16       Impact factor: 4.488

4.  Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis.

Authors:  Matteo Fassan; Luigi Dall'Olmo; Marco Galasso; Chiara Braconi; Marco Pizzi; Stefano Realdon; Stefano Volinia; Nicola Valeri; Pierluigi Gasparini; Raffaele Baffa; Rhonda F Souza; Caterina Vicentini; Edoardo D'Angelo; Jan Bornschein; Gerard J Nuovo; Giovanni Zaninotto; Carlo M Croce; Massimo Rugge
Journal:  Oncotarget       Date:  2014-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.